SC Filed 2022-03-04 Event — SEC 0001140361-22-008013 →

VIKING GLOBAL INVESTORS LP → Ginkgo Bioworks Holdings, Inc. DNABW

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 31/100 · Filer 90d Win Rate: 75% · Hist. 90d Edge: +0.2%

Filer track record (5 filings): 75% 90d win rate, +7.1% 90d edge
Held by 2 tracked 13F institutional managers

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

23 filings by this filer

22 other filings in the data moat

Short Interest · settle 2026-09-15

DTC 1.00

10,871 shares short · 0.0% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

2 holders · $36.09M

Point72 Asset MgmtViking Global

Other 13D/G Filings on Ginkgo Bioworks Holdings, Inc.

Filed	Form	Filer	Stake	Shares
2025-02-14	SCHEDULE	Shetty Reshma P.	9.50%	4,716,084	view →
2023-01-25	SC	Kelly Jason R	—	—	view →
2022-10-05	SC	Shetty Reshma P.	—	—	view →
2021-10-01	SC	VIKING GLOBAL INVESTORS LP	—	—	view →

Other Filings by VIKING GLOBAL INVESTORS LP

Filed	Form	Issuer	Stake	Shares
2026-09-16	SCHEDULE 13G	REGAL REXNORD CORP	—	—	view →
2026-07-10	SCHEDULE 13D/A	BridgeBio Pharma, Inc. BBIO	5.00%	9,792,219	view →
2026-06-12	SCHEDULE 13D	STANDARD BIOTOOLS INC. LAB	15.00%	58,651,170	view →
2026-05-18	SCHEDULE 13G	Artiva Biotherapeutics, Inc. ARTV	—	—	view →
2026-04-02	SCHEDULE 13D/A	BridgeBio Pharma, Inc. BBIO	6.10%	11,842,434	view →
2025-07-01	SCHEDULE	BridgeBio Pharma, Inc. BBIO	9.80%	18,602,920	view →
2025-01-31	SCHEDULE	BridgeBio Pharma, Inc. BBIO	11.70%	22,055,375	view →
2023-11-07	SC	Cazoo Group Ltd	—	—	view →
2023-09-22	SC	Cazoo Group Ltd	—	—	view →
2023-07-20	SC	BridgeBio Pharma, Inc. BBIO	—	—	view →
2023-04-27	SC	Cazoo Group Ltd	—	—	view →
2023-02-27	SC	Cazoo Group Ltd	—	—	view →
2021-10-01	SC	Ginkgo Bioworks Holdings, Inc. DNABW	—	—	view →
2019-07-12	SC	Myovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-07-12	SC	Urovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Axovant Gene Therapies Ltd.	—	—	view →
2019-03-19	SC	Axovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-01-03	SC	Urovant Sciences Ltd.	—	—	view →

Showing 20 of 22

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →